MYDA Advisors’s Astera Labs ALAB Stock Holding History

MYDA Advisors’s Portfolio ALAB Stock Details ALAB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-4,000	Closed	-$297K	–	166
2024 Q1	$297K	Buy	+4,000	New	+$296K	0.08%	96

Other funds holding ALAB

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Intel Corp Santa Clara, California $470M AUM 21.74% 1-Year Est. Return

Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Maverick Capital Dallas, Texas $8.67B AUM 48.76% 1-Year Est. Return

SPPAM

Summit Partners Public Asset Management Boston, Massachusetts $3.72B AUM 162.29% 1-Year Est. Return

MYDA Advisors's ALAB Position: Q2 2024 in Review

MYDA Advisors sold out of Astera Labs (ALAB) in Q2 2024, closing a stake of 4,000 shares — an estimated $297K sold.

MYDA Advisors first reported a position in ALAB in Q1 2024 and held it in 1 quarter. The position peaked at $297K in Q1 2024. 146 funds tracked by Wall St. Rank hold ALAB as of Q2 2024.

MYDA Advisors reported no remaining Astera Labs position as of Q2 2024 after selling out during the quarter.
MYDA Advisors sold 4,000 Astera Labs shares in Q2 2024, an estimated $297K.
MYDA Advisors first reported a position in Astera Labs in Q1 2024 and held it in 1 quarter.
MYDA Advisors's Astera Labs position peaked at $297K in Q1 2024.
146 funds tracked by Wall St. Rank held Astera Labs as of Q2 2024.

Based on MYDA Advisors's 13F filing for Q2 2024, filed 13 Aug 2024.